Breaking News

AMRI Gains Potent API Safety Certification

AMRI has received certification of its high potency research labs and GMP-manufacturing facilities in Rensselaer, NY for the safe handling of potent APIs by SafeBridge Consultants, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI has received certification of its high potency research labs and GMP-manufacturing facilities in Rensselaer, NY for the safe handling of potent APIs by SafeBridge Consultants, Inc. The SafeBridge Potent Compound Safety Certification applies to specific AMRI labs and manufacturing areas designed for the research, development and manufacture of potent compounds and certifies AMRI is competent and proficient in the safe handling of potent APIs.

AMRI’s certified facilities in Rensselaer include jacketed glass reactors, portable Hastelloy or glass-lined kettles, portable and fixed pressure filters/dryers, HPAPI isolators, as well as particle size reduction technology.

“Receiving SafeBridge certification demonstrates AMRI’s scientific and operational expertise in working safely with highly potent compounds, as well as the company’s commitment to provide customers with products and services that meet the highest standards for quality and regulatory, safety and environmental compliance,” said AMRI chairman, president and chief executive officer Thomas E. D’Ambra, Ph.D.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters